World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
130176
World Ranking
1249
National Ranking
726

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Daniel F. Hayes is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on areas within medicine and biochemistry, genetics, and molecular biology, with significant contributions to oncology, cancer research, pulmonary and respiratory medicine, genetics, and molecular biology subfields.

The scientist has published extensively on topics related to breast cancer treatment studies, advanced breast cancer therapies, and cancer genomics and diagnostics. Other highlighted topics include cancer cells and metastasis, cancer treatment and pharmacology, estrogen and related hormone effects, and HER2/EGFR in cancer research.

Their recent published papers include:

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update, 2020, Journal of Clinical Oncology
  • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group, 2020, JNCI Journal of the National Cancer Institute
  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update, 2023, Journal of Clinical Oncology
  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update, 2020, Archives of Pathology & Laboratory Medicine
  • Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors, 2021, JAMA Oncology

Daniel F. Hayes often collaborates with several coauthors, notably William E. Barlow, James M. Rae, Kathy S. Albain, Gabriel N. Hortobágyi, and Lajos Pusztai, each with numerous joint publications, reflecting ongoing collaborative research efforts.

The main publication venues for their work include:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Breast Cancer Research and Treatment

Daniel F. Hayes has been recognized as a member of the Association of American Physicians.

Best Publications

  • American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    M. Elizabeth H. Hammond;Daniel F Hayes;Mitch Dowsett;D Craig Allred

  • American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

    Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty

  • Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

    Massimo Cristofanilli;G. Thomas Budd;Matthew J. Ellis;Alison Stopeck

  • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

    Antonio C. Wolff;M. Elizabeth H. Hammond;Jared N. Schwartz;Karen L. Hagerty

  • ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

    Christophe Ginestier;Min Hee Hur;Emmanuelle Charafe-Jauffret;Florence Monville

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

    Lyndsay Harris;Herbert Fritsche;Robert Mennel;Larry Norton

  • Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

    Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett

  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    Joseph A. Sparano;Robert J. Gray;Della F. Makower;Kathleen I. Pritchard

  • EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

    Celina G. Kleer;Qi Cao;Sooryanarayana Varambally;Ronglai Shen

  • ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

    Gershon Y. Locker;Stanley R Hamilton;Jules Harris;John M. Jessup

  • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    Kathy S Albain;William E Barlow;Steven Shak;Gabriel N Hortobagyi

  • Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    I. Craig Henderson;Donald A. Berry;George D. Demetri;Constance T. Cirrincione

  • American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

    Carmen J. Allegra;Carmen J. Allegra;J. Milburn Jessup;Mark R. Somerfield;Stanley R. Hamilton

  • Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

    Mark D. Pegram;Allen Lipton;Daniel F. Hayes;Barbara L. Weber

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

    Fitzgibbons Pl;Page Dl;Weaver D;Thor Ad

  • Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn

  • Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard

  • 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

    Hongchao Pan;Richard Gray;Jeremy Braybrooke;Christina Davies

Frequent Co-Authors

Vered Stearns
Vered Stearns Johns Hopkins University
William E. Barlow
William E. Barlow Fred Hutchinson Cancer Research Center
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
David A. Flockhart
David A. Flockhart Indiana University
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Giuseppe Viale
Giuseppe Viale University of Milan
Lori J. Pierce
Lori J. Pierce University of Michigan–Ann Arbor
Robert B. Livingston
Robert B. Livingston University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but looking for alternative or supportive career paths, there are a variety of online degree programs worth considering. Online nursing degrees, for example, have become a popular and flexible option for those entering or advancing in the healthcare field.

For individuals seeking entry-level qualifications, online nursing programs provide a practical route to becoming a licensed nurse, combining affordability with schedule flexibility. Those who are already registered nurses and want to enhance their credentials can benefit from the cheapest online RN to BSN programs, allowing them to earn a bachelor’s degree while continuing to work.

For advanced clinical practice, affordable NP programs offer a pathway to become a nurse practitioner, an in-demand role with expanded responsibilities. Ambitious professionals interested in research or academic leadership may explore online PhD nursing programs to build expertise and open new career doors.

Exploring these online pathways can help you tailor your medical career, align with personal goals, and manage costs more efficiently.

Best Scientists Citing Daniel F. Hayes

Trending Scientists

Recently Published Articles